Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study
<h4>Introduction</h4> There is currently no test for pelvic inflammatory disease (PID) that is non-invasive and sufficiently sensitive and specific. Clinicians must therefore diagnose PID clinically, ruling out medical emergencies and conducting pelvic examinations where possible. While...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484633/?tool=EBI |
_version_ | 1828733580910526464 |
---|---|
author | Helen Bittleston Jane S. Hocking Jane L. Goller Jacqueline Coombe Deborah Bateson Sally Sweeney Kirsteen Fleming Wilhelmina M. Huston |
author_facet | Helen Bittleston Jane S. Hocking Jane L. Goller Jacqueline Coombe Deborah Bateson Sally Sweeney Kirsteen Fleming Wilhelmina M. Huston |
author_sort | Helen Bittleston |
collection | DOAJ |
description | <h4>Introduction</h4> There is currently no test for pelvic inflammatory disease (PID) that is non-invasive and sufficiently sensitive and specific. Clinicians must therefore diagnose PID clinically, ruling out medical emergencies and conducting pelvic examinations where possible. While guidelines state that clinicians should be prepared to over-diagnose PID, it remains an under-diagnosed condition, with severe reproductive health impacts when left untreated. This research is the first to consider the perspectives of end-users on the development of a diagnostic test for PID. <h4>Methods</h4> Semi-structured live video feed online (Zoom) interviews were conducted with 11 clinicians and nine women (aged 18–30 years) in Australia to understand how a diagnostic test might be used, and what characteristics a test would need for it to be acceptable to clinicians and young women. Participants were recruited via researcher and university student networks. Reflexive thematic analysis was used to identify key themes relating to the acceptability and characteristics of a diagnostic test for PID. <h4>Results</h4> Seven general practitioners, four clinicians working in sexual health clinics, and nine young women (aged 21–27 years) were interviewed. Clinicians were aged between 31–58 years and were predominantly female. Clinicians recognised that the development of an accurate test to diagnose PID would be valuable to themselves and other clinicians, particularly those who lack experience diagnosing PID, and those working in certain settings, including emergency departments. They discussed how they might use a test to enhance their clinical assessment but highlighted that it would not replace clinical judgement. Clinicians also considered how a test would impact the patient experience and time to treatment, emphasising that it should be minimally invasive and have a quick turnaround time. Young women said a test would be acceptable if endorsed by a trustworthy clinician. <h4>Conclusions</h4> PID remains a challenging diagnosis. Development of a minimally invasive and sufficiently accurate diagnostic test would be acceptable to young women and benefit some clinicians, although no test would completely replace an experienced clinician’s judgement in making a PID diagnosis. |
first_indexed | 2024-04-12T22:32:14Z |
format | Article |
id | doaj.art-e6f6e556b5a24b60a2b6ee9d5cf9f850 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-04-12T22:32:14Z |
publishDate | 2022-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-e6f6e556b5a24b60a2b6ee9d5cf9f8502022-12-22T03:13:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01179Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative studyHelen BittlestonJane S. HockingJane L. GollerJacqueline CoombeDeborah BatesonSally SweeneyKirsteen FlemingWilhelmina M. Huston<h4>Introduction</h4> There is currently no test for pelvic inflammatory disease (PID) that is non-invasive and sufficiently sensitive and specific. Clinicians must therefore diagnose PID clinically, ruling out medical emergencies and conducting pelvic examinations where possible. While guidelines state that clinicians should be prepared to over-diagnose PID, it remains an under-diagnosed condition, with severe reproductive health impacts when left untreated. This research is the first to consider the perspectives of end-users on the development of a diagnostic test for PID. <h4>Methods</h4> Semi-structured live video feed online (Zoom) interviews were conducted with 11 clinicians and nine women (aged 18–30 years) in Australia to understand how a diagnostic test might be used, and what characteristics a test would need for it to be acceptable to clinicians and young women. Participants were recruited via researcher and university student networks. Reflexive thematic analysis was used to identify key themes relating to the acceptability and characteristics of a diagnostic test for PID. <h4>Results</h4> Seven general practitioners, four clinicians working in sexual health clinics, and nine young women (aged 21–27 years) were interviewed. Clinicians were aged between 31–58 years and were predominantly female. Clinicians recognised that the development of an accurate test to diagnose PID would be valuable to themselves and other clinicians, particularly those who lack experience diagnosing PID, and those working in certain settings, including emergency departments. They discussed how they might use a test to enhance their clinical assessment but highlighted that it would not replace clinical judgement. Clinicians also considered how a test would impact the patient experience and time to treatment, emphasising that it should be minimally invasive and have a quick turnaround time. Young women said a test would be acceptable if endorsed by a trustworthy clinician. <h4>Conclusions</h4> PID remains a challenging diagnosis. Development of a minimally invasive and sufficiently accurate diagnostic test would be acceptable to young women and benefit some clinicians, although no test would completely replace an experienced clinician’s judgement in making a PID diagnosis.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484633/?tool=EBI |
spellingShingle | Helen Bittleston Jane S. Hocking Jane L. Goller Jacqueline Coombe Deborah Bateson Sally Sweeney Kirsteen Fleming Wilhelmina M. Huston Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study PLoS ONE |
title | Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study |
title_full | Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study |
title_fullStr | Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study |
title_full_unstemmed | Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study |
title_short | Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study |
title_sort | is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care an exploratory qualitative study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484633/?tool=EBI |
work_keys_str_mv | AT helenbittleston isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy AT janeshocking isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy AT janelgoller isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy AT jacquelinecoombe isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy AT deborahbateson isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy AT sallysweeney isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy AT kirsteenfleming isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy AT wilhelminamhuston isthereaplaceforamoleculardiagnostictestforpelvicinflammatorydiseaseinprimarycareanexploratoryqualitativestudy |